Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population

Cellular and Molecular Biology

Volumn 61, Issue 6, 2015, Pages 108-112

  Zahoor, A ^a,b   Mansoor, Q ^a   Farooqi, Ammad Ahmad ^a   Fayyaz, S ^c   Naz, G ^b   Ismail, M ^a  

^a INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^b INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^c RASHID LATIF MEDICAL COLLEGE   (Pakistan)

Author keywords

Apoptosis; Cancer; DR4; Signaling; TRAIL

Indexed keywords

ADULT; ALLELE; AMPLIFICATION REFRACTORY MUTATION SYSTEM; ANALYTIC METHOD; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; DEATH RECEPTOR 4 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAKISTANI; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRAIL GENE; COLORECTAL TUMOR; GENETICS; MUTATION; PAKISTAN;

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADULT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MUTATION; PAKISTAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84962165962     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2015.61.6.14     Document Type: Article

References (30)

1. Zeki, S.S., Graham, T.A., Wright, N.A. Stem cells and their implications for colorectal cancer. Nat Rev. Gastroenterol. Hepatol. 2011, 8:90-100.
2. Kedrin, D., Gala, M.K. Genetics of the serrated pathway to colorectal cancer. Clin. Transl. Gastroenterol. 2015, 6: e84.
3. Oikonomou, E., Pintzas, A. The TRAIL of oncogenes to apoptosis. Biofactors. 2013, 39:343-54.
4. Stuckey, D.W., Shah, K. TRAIL on trial: preclinical advances in cancer therapy. Trends Mol. Med. 2013, 19:685-94.
5. Alexiou, G.A., Tsamis, K.I., Kyritsis, A.P. Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas. Semin. Pediatr. Neurol. 2015, 22:35-39.
6. Trivedi, R., Mishra, D.P. Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells. Front. Oncol. 2015, 5:69.
7. Wang, F., Lin, J., Xu, R. The molecular mechanisms of TRAIL resistance in cancer cells: help in designing new drugs. Curr. Pharm. Des. 2014, 20:6714-22.
8. Twomey, J.D., Kim, S.R., Zhao, L., Bozza, W.P., Zhang, B. Spatial dynamics of TRAIL death receptors in cancer cells. Drug Resist. Updat. 2015, 19:13-21.
9. Taştemir-Korkmaz, D., Demirhan, O., Kuleci, S., Hastürk, S. There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population. Pathol. Oncol. Res. 2013, 19:779-84.
10. Verim, A., Turan, S., Farooqi, A.A., Kahraman, O.T., Tepe-Karaca, C., Yildiz, Y., Naiboglu, B., Ozkan, N.E., Ergen, A., Isitmangil, G.A., Yaylim, I. Association between Laryngeal Squamous Cell Carcinoma and Polymorphisms in Tumor Necrosis Factor Related Apoptosis Induce Ligand (TRAIL), TRAIL Receptor and sTRAIL Levels. Asian Pac. J. Cancer Prev. 2014, 15:10697-703.
11. Mittal, R.D., Srivastava, P., Mittal, T., Verma, A., Jaiswal, P.K., Singh, V., Mandal, R.K., Mandhani A. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians. Eur. J. Surg. Oncol. 2011, 37:727-33.
12. Ulybina, Y.M., Kuligina, ESh., Mitiushkina, N.V., et al. Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett. 2009, 278:183-91.
13. Kuraoka, K., Matsumura, S., Sanada, Y., Nakachi, K., Imai, K., Eguchi, H., Matsusaki, K., Oue, N., Nakayama, H., Yasui, W. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan. Oncol. Rep, 2005, 14:465-70.
14. Frank, B., Hemminki, K., Shanmugam, K.S., et al. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. Carcinogenesis. 2005, 26:1975-7.
15. Frank, B., Shanmugam, K.S., Beckmann, L., Hemminki, K., Brenner, H., Hoffmeister, M., Chang-Claude, J., Burwinkel, B. Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2002-5.
16. Hazra, A., Chamberlain, R.M., Grossman, H.B., Zhu, Y., Spitz, M.R., Wu, X. Death receptor 4 and bladder cancer risk. Cancer Res. 2003, 63:1157-9.
17. Fisher, M.J., Virmani, A.K., Wu, L., et al. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin. Cancer Res. 2001, 7:1688-97.
18. Wang, C., Xu, S., Yi, F., Wang, X., Lei, Y., Huang, S., Zhou, R., Xia, B. Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China. Pharm. Res. 2015, 32:762-8.
19. Li, Y., Ahmad, A., Sarkar and F. H., ASPP and iASPP: Implication in cancer development and progression. Cell. Mol. Biol. 2015, 61(6):2-8.
20. Masood, N., Qureshi, M. Z. and Yasmin, A., Association of NOTCH with different microRNAs in head and neck cancer. Cell. Mol. Biol. 2015, 61(6):9-16.
21. Amirkhah, R., Farazmand, A., Irfan-Maqsood, M., Wolkenhauerand, O. and Schmitz, U., The role of microRNAs in the resistance to colorectal cancer treatments. Cell. Mol. Biol. 2015, 61(6):17-23.
22. Wang, Z., Chen, J. and Capobianco, A. J., The Notch signaling pathway in esophageal adenocarcinoma. Cell. Mol. Biol. 2015, 61(6):24-32.
23. Limami, Y., Pinon, A., Riaz, A. and Simon, A., TRAIL and targeting cancer cells: between promises and obstacles. Cell. Mol. Biol. 2015, 61(6):33-38.
24. Silva Galbiatti-Dias, A. L., Pavarino, É. C., Kawasaki-Oyama, R. S., Maniglia, J. V., Maniglia, E. J. V. and Goloni Bertollo, E. M., Cancer stem cells in head and neck cancer: A Mini Review. Cell. Mol. Biol. 2015, 61(6):39-43.
25. Musella, A., Marchetti, C., Gasparri, M. L., Salerno, L., Casorelli, A., Domenici, L., Imperiale, L., Ruscito, I., Abdul Halim, T., Palaia, I., Di Donato, V., Pecorini, F., Monti, M., Muzii, L. and Panici, P. B., PARP inhibition: A promising therapeutic target in ovarian cancer. Cell. Mol. Biol. 2015, 61(6):44-61.
26. Attar, R., Tabassum, S., Fayyaz, S., Ahmad, M. S., Nogueira, D. R., Yaylim, I., Timirci-Kahraman, O., Kucukhuseyin, O., Cacina, C., Farooqi, A. A. and Ismail, M., Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites. Cell. Mol. Biol. 2015, 61(6):62-68.
27. Hsu, Y-C., Hsieh, Y-H., Liao, C-C., Chong, L-W., Lee, C-Y., Yu, Y-L. and Chou, R-H., Targeting post-translational modifications of histones for cancer therapy. Cell. Mol. Biol. 2015, 61(6):69-84.
28. Chong, L-W., Chou, R-H., Liao, C-C., Lee, T-F., Lin, Y., Yang, K-C. and Hsu, Y-C. Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells. Cell. Mol. Biol. 2015, 61(6):85-91.
29. Smina, T. P., Mohan, A., Ayyappa, K. A., Sethuraman, S. and Krishnan, U. M., Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins. Cell. Mol. Biol. 2015, 61(6):92-99.
30. Ahmadi, M., Jafari, R., Marashi, S. A. and Farazmand, A., Indirect role of microRNAs and transcription factors in the regulation of important cancer genes: A network biology approach. Cell. Mol. Biol. 2015, 61(6):100-107.